Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 1283 | Longs Won 683/1283 53% | Profit Factor 1.31 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1,614.13 |
| Average Win $633.47 | Best Trade (Aug 12) $13,124.27 | Sharpe Ratio -237.85 |
| Average Loss -$551.3 | Worst Trade (Aug 15) -$23,455.26 | Z-Score -10.84 (100%) |
| Commissions $0 | Avg. Trade Length 2m 2w 3d | Expectancy $79.41 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% | 0.19% | 1.27% | 6.5% | 27.52% |
| Consecutive Losing Trades | 366 | 330 | 293 | 256 | 220 | 183 | 146 | 110 | 73 | 37 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
CAPR Capricor Therapeutics Inc. | 30,358.25 | $201,882.37 | $201,882.37 | - | - | - | +57.957% |